ArticleCell death & disease2014

HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.

R Schulz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.